Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective, randomized study of the efficacy of photodynamic therapy in actinic keratosis
2008-000459-88Phase 3Completed
- Sponsor
- University Hospital RWTH Aachen
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of 5-aminolevulinic acid in actinic keratosis (AK) (2 arms), sponsored by University Hospital RWTH Aachen. Primary endpoint: Final treatment outcome at 6 months. Started Oct 2008; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2008-000459-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000459-88.